Squamous Carcinoma Terminated Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Carcinoma, Squamous

IndicationStatusPhase
DBCOND0076732 (Squamous Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00591149Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerTreatment